Inhibikase Therapeutics Inc logo

Inhibikase Therapeutics Inc

NEW
NAS:IKT (USA)   Ordinary Shares
$ 2.11 +0.095 (+4.71%) 11:08 PM EST
At Loss
P/B:
1.66
Market Cap:
$ 331.34M
Enterprise V:
$ 243.71M
Volume:
1.74M
Avg Vol (2M):
898.50K
Trade In:
Volume:
1.74M
At Loss
Avg Vol (2M):
898.50K

Inhibikase Therapeutics Inc Operating Data

Inhibikase Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Inhibikase Therapeutics Inc (IKT) Operating Data Charts